Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-19
2011-04-19
Anderson, James D. (Department: 1614)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S279000, C514S183000, C546S112000
Reexamination Certificate
active
07928238
ABSTRACT:
The invention is directed to compounds of Formula (I) described herein useful as CETP inhibitors, compositions containing them, and methods of using them.
REFERENCES:
patent: 5580885 (1996-12-01), King et al.
patent: 5616537 (1997-04-01), Yokota et al.
patent: 5770544 (1998-06-01), Yokota et al.
patent: 6051601 (2000-04-01), Dombroski et al.
patent: 6093573 (2000-07-01), Beamer et al.
patent: 6262074 (2001-07-01), Otten et al.
patent: 6476075 (2002-11-01), Sikorski et al.
patent: 6479436 (2002-11-01), Otten et al.
patent: 6642228 (2003-11-01), Hayashi et al.
patent: 6713508 (2004-03-01), Sahoo et al.
patent: 7015219 (2006-03-01), Dickson et al.
patent: 7125891 (2006-10-01), Breslin et al.
patent: 2002/0013314 (2002-01-01), Zhu et al.
patent: 2003/0162777 (2003-08-01), Leonardi et al.
patent: 2003/0181446 (2003-09-01), Leonardi et al.
patent: 2004/0034089 (2004-02-01), Breslin et al.
patent: 2004/0039018 (2004-02-01), Ruggeri
patent: 2005/0113368 (2005-05-01), Bhuniya et al.
patent: 2006/0276509 (2006-12-01), Breslin et al.
patent: 0 198 264 (1986-03-01), None
patent: 0 801 060 (1997-03-01), None
patent: WO 93/05038 (1993-03-01), None
patent: WO 94/01415 (1994-01-01), None
patent: WO 96/11920 (1996-04-01), None
patent: WO 96/15099 (1996-05-01), None
patent: WO 98/12180 (1998-03-01), None
patent: WO 98/12192 (1998-03-01), None
patent: WO 00/78716 (2000-12-01), None
patent: WO 01/12187 (2001-02-01), None
patent: WO 01/57003 (2001-08-01), None
patent: WO 02/36116 (2002-05-01), None
patent: WO 03/031436 (2003-04-01), None
patent: WO 2004/037788 (2004-05-01), None
patent: WO 2004/072041 (2004-08-01), None
patent: WO 2004/072042 (2004-08-01), None
Hesler et al., J. Biol. Chem., 262:2275-2282, 1987.
Au-Young and Fielding, Proc. Natl. Acad. Sci., 89:4094-4098, 1992.
Bruce et al., Curr. Opin. Struct. Biol., 8:426-434, 1998.
Marcel et al., Journal of Clinical Investigation, 85:10-17, 1990.
McPherson et al., Arteriosclerosis and Thrombosis: A Jounral of Vascular Biology, 11(4):797-804, 1991.
Nishida et al., Journal of Biological Chemistry, 268(22):16352-60, 1993.
Guerin et al., Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14(5):679-85, 1994.
Guerin et al., Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 14(2):199-206, 1994.
Packard and Shepard, ARterscler. Thromb. Vasc. Biol., 17:3542-3556, 1997.
Guerin et al., European Journal of Clinical Investigation, 26(6):485-94, 1996.
Guerin et al, Arterioscloerosis, Thrombosis and Vascular Biology, 20(1):189-97, 2001.
Sugano et al., Journal of Biological Chemistry, 273(9):5033-6, 1998.
Rittershaus et al., Arteriosclerosis, Thrombosis and Vascular Biology, 20(9) :2106-2112, 2000.
Whitlock et al., Journal of Cinical Investigation, 84(1) :129-37, 1989.
Okamoto et al., Nature, 406:203-207, 2000.
Huang et al., Clin. Sci., 103(6):587-594, 2002.
DeGrooth et al., Circulation, 105(18):2159-2165, 2002.
Brousseau et al., New England Journal of Medicine, 350(15) :1505-1515, 2004.
Berge et al., “Pharmaceutical Salts.”, J. Pharm.Sci., 1977, vol. 66(1), pp. 1-19.
Connolly et al., “Sterospecific Inhibition of CETP by ChiralN,N-Disubstituted Trifluoro-3-amino-2-propanols.”, Biochemistry, 2000, vol. 39, pp. 13870-13879.
Gould P.L., “Salt Selection for Basic Drugs.”, International J. Pharm., 1986, vol. 33, pp. 201-217.
Still et al., “Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution.”, J. Org. Chem., 1978, vol. 43(14), pp. 2923-2925.
Tashiro et al., “Preparation of Bromobenzoic Acids From the Corresponding Bromotoluenes Via the Krohke Method.”, Organic Preparations and Procedures International, 1984, vol. 16(5), pp. 379-383.
International Search Report, International U.S. Appl. No. PCT/US2007/068628, Date of Mailing of International Search Report, Apr. 28, 2008.
Written Opinion of International Search Authority relating to International Application No. PCT/US2007/068628, Date of Mailing of Written Opinion, Apr. 28, 2008.
Translation of EP0198264.
Demarest Keith T.
Kuo Gee-Hong
Pelton Patricia
Rano Thomas
Sieber-McMaster Ellen
Anderson James D.
Finn Meghan
Janssen Pharmaceutica NV
LandOfFree
1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydro-quinoline derivatives as CETP inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619663